3092
B. Kaboudin et al.
PAPER
HRMS: m/z [M + H+] calcd for C15H13N3SCl2: 338.0285; found:
HRMS: m/z [M + H+] calcd for C23H19N3S: 370.1378; found:
338.0283.
370.1397.
4,6-Di(2-fluorophenyl)[1,3,5]triazinane-2-thione (2g)
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
2.88 (t, J = 11.5 Hz, 1 H, NH), 3.10–3.40 (br, 1 H, NH), 5.98 (s,
2 H), 6.23 (d, J = 11.5 Hz, 2 H), 7.20–8.30 (m, 20 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
59.5 (d, JC–F = 3.8 Hz), 116.0 (d, JC–F = 21.4 Hz), 124.7, 127.2 (d,
JC–F = 12.6 Hz), 129.0 (d, JC–F = 3.1 Hz), 130.8 (d, JC–F = 8.2 Hz),
159.9 (d, JC–F = 247.2 Hz), 177.0.
4,6-Di(b-naphthyl)[1,3,5]triazinane-2-thione (2m)
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
2.10–2.40 (br, 1 H, NH), 2.60–2.80 (br, 1 H, NH), 5.30–5.45 (br,
2 H), 5.70–5.85 (br, 2 H), 6.90–7.05 (br, 2 H, NH), 7.15–8.30 (m,
30 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
69.3, 125.8, 126.6, 127.9, 128.0, 128.4, 132.9, 133.3, 137.0, 178.0.
HRMS: m/z [M + H+] calcd for C23H19N3S: 370.1378; found:
370.1400.
HRMS: m/z [M + H+] calcd for C15H13N3SF2: 306.0877; found:
306.0890.
4,6-Di(2-furyl)[1,3,5]triazinane-2-thione (2n)
4,6-Di(2-methylphenyl)[1,3,5]triazinane-2-thione (2h)
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
1.78 (t, J = 12.25 Hz, 1 H, NH), 2.15 (s, 6 H), 2.28 (t, J = 8.5 Hz,
1 H, NH), 2.44 (s, 6 H), 5.32 (d, J = 8.5 Hz, 2 H), 5.76 (d, J = 12.25
Hz, 2 H), 6.99 (s, 2 H, NH), 7.10–7.55 (m, 18 H).
13C NMR (CDCl3, 62.9 MHz): d (mixture of two diastereoisomers) =
18.31, 18.77, 63.4, 66.45, 124.4, 125.8, 126.1, 126.7, 128.9, 129.4,
131.0, 131.1, 135.3, 135.9, 136.3, 136.4, 177.7, 179.3.
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
2.59 (t, J = 12.25 Hz, 1 H, NH), 2.85–3.00 (br, 1 H, NH), 5.39 (d,
J = 8.0 Hz, 2 H), 6.23 (d, J = 12.25 Hz, 2 H), 6.38–6.55 (m, 8 H),
7.19 (s, 2 H, NH), 7.30–7.55 (m, 6 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
60.0, 108.7, 110.6, 143.3, 153.0, 176.2.
HRMS: m/z [M + Na+] calcd for C11H11N3O2S: 272.0470; found:
272.0442.
HRMS: m/z [M + H+] calcd for C17H19N3S: 298.1378; found:
298.1375.
Acknowledgment
4,6-Di(3-fluorophenyl)[1,3,5]triazinane-2-thione (2i)
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
2.88 (t, J = 11.5 Hz, 1 H, NH), 3.10–3.40 (br, 1 H, NH), 5.98 (s,
2 H), 6.23 (d, J = 11.5 Hz, 2 H), 7.20–8.30 (m, 20 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
64.4, 113.9 (d, JC–F = 22.6 Hz), 115.3 (d, JC–F = 20.8 Hz), 123.1 (d,
JC–F = 1.9 Hz), 130.7 (d, JC–F = 8.2 Hz), 142.5 (d, JC–F = 6.9 Hz),
162.2 (d, JC–F = 244.7 Hz), 175.8.
The Institute for Advanced Studies in Basic Sciences (IASBS) is
thanked for supporting this work. The authors thank Mr. Haruhiko
Fukaya, Tokyo University of Pharmacy and Life Sciences for help
in carrying out the X-ray crystallographic analysis.
References
(1) Roth, H. J.; Kleemann, A. Pharmaceutical Chemistry, Drug
Synthesis, Vol. 1; Wiley: New York, 1990.
HRMS: m/z [M + H+] calcd for C15H13N3SF2: 306.0877; found:
306.0890.
(2) (a) Giumanini, A. G.; Verardo, G.; Gorassini, F.; Strazzolini,
P.; Benetollo, F.; Bombieri, G. J. Chem. Soc., Perkin Trans.
1 1994, 1643. (b) Groendaal, B.; Vugts, D. J.; Schmitz, R.
F.; de Kanter, F. J. J.; Ruijter, E.; Groen, M. B.; Orru, R. V.
A. J. Org. Chem. 2008, 73, 719. (c) Soliman, A. A.-W.
J. Chem. Eng. Data 1984, 29, 99.
4,6-Di(2,4-dichlorophenyl)[1,3,5]triazinane-2-thione (2j)
1H NMR (CDCl3, 250 MHz): d (single diastereoisomer, trans) =
4.29 (t, J = 12.25 Hz, 1 H, NH), 6.34 (d, J = 12.25 Hz, 2 H), 6.84 (s,
2 H, NH), 7.20–7.48 (m, 6 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
(3) Perry, A. A.; Virgel, E. G.; Brian, P. L. US Patent 3689651,
1972.
66.3, 129.0–136.0 (Ar), 178.0.
(4) Fukami, H.; Hashimoto, M.; Niwata, S.; Imose, J.;
Kawaguchi, H.; Takahashi, T. US Patent 5424310, 1995.
(5) Klenke, B.; Barrett, M. P.; Brun, R.; Gilbert, I. H.
J. Antimicrob. Chemother. 2003, 52, 290.
(6) Kinyanjui, S. M.; Mberu, E. K.; Winstanley, P. A.; Jacobus,
D. P.; Watkins, W. M. Am. J. Trop. Med. Hyg. 1999, 60, 943.
(7) Soong, Ch.-L.; Ogawa, J.; Sakuradani, E.; Shimizu, S.
J. Biol. Chem. 2002, 227, 7051.
HRMS: m/z [M + H+] calcd for C15H11N3SCl4: 405.9506; found:
405.9523.
4,6-Di(2,6-dichlorophenyl)[1,3,5]triazinane-2-thione (2k)
1H NMR (CDCl3, 250 MHz): d = (single diastereoisomer, trans) =
4.29 (t, J = 12.25 Hz, 1 H, NH), 6.37 (d, J = 12.25 Hz, 2 H), 6.65–
6.90 (br, 2 H, NH), 7.20–7.48 (m, 6 H).
13C NMR (DMSO-d6, 62.9 MHz): d (single diastereoisomer, trans) =
66.3, 129.0–136.0 (Ar), 178.0.
(8) Bakke, J. M.; Buhaug, J. B. Ind. Eng. Chem. Res. 2004, 43,
1962.
(9) Sugimoto, H.; Yamane, Y.; Inoue, S. Tetrahedron:
Asymmetry 2000, 11, 2067.
(10) (a) Murray, A. P.; Miller, M. J. J. Org. Chem. 2003, 68, 191.
(b) Ghosh, M.; Miller, M. J. J. Org. Chem. 1994, 59, 1020.
(11) Zhang, Z.; Xian, D.; Li, J.; Zhang, G. Acta Crystallogr., Sect.
C 2008, 64, o191.
(12) (a) Enders, E.; Ebbighausen, V.; Gau, W.; Wunsche, C.;
Stendel, W. US Patent 4 173 645, 1979. (b) Lenzen, S.;
Ahmad, R. German Patent DE 10 012 401, 2001.
(c) Acharya, A. N.; Ostresh, J. M.; Houghten, R. A. J. Comb.
Chem. 2001, 3, 612.
HRMS: m/z [M + H+] calcd for C15H11N3SCl4: 405.9506; found:
405.9562.
4,6-Di(a-naphthyl)[1,3,5]triazinane-2-thione (2l)
1H NMR (CDCl3, 250 MHz): d (mixture of two diastereoisomers) =
2.45 (t, J = 11.75 Hz, 1 H, NH), 2.78 (t, J = 8.5 Hz, 1 H, NH), 5.92
(d, J = 8.5 Hz, 2 H), 6.47 (d, J = 11.75 Hz, 2 H), 7.0–7.1 (br, 2 H,
NH), 7.15–8.30 (m, 30 H).
13C NMR (CDCl3, 62.9 MHz): d (mixture of two diastereoisomers) =
67.6, 70.4, 128.8, 129.1, 129.3, 129.8, 130.1, 130.2, 130.7, 130.9,
131.0, 131.2, 133.5, 133.6, 133.7, 134.0, 135.3, 135.8, 138.4, 138.6,
139.6, 139.9, 182.4, 183.9.
Synthesis 2009, No. 18, 3089–3093 © Thieme Stuttgart · New York